-
Huadong Medicine and Aussino Biotech Announce Exclusive Strategic Collaboration on Improved Oral For...
On July 12, 2024, Huadong Medicine Co., Ltd., through its wholly-owned subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. and Suzhou Aussin...
2024-07-15 16:53 -
Balancing Investments in the Dynamic Pharmaceutical Industry
Amgen acquired Celgene's global rights to the psoriasis drug Otezla for a staggering $13.4 billion, raising doubts about whether such a massive invest...
2024-07-15 16:51 -
Sravanti Therapy: Emerging Frontier in EGFR-Mutant and MET-Positive Advanced NSCLC
The key evaluation endpoint of this Phase II, single-arm study on the efficacy and safety of sravanti in EGFR-mutant and MET-overexpressing and/or MET...
2024-07-15 16:50 -
Challenges Emerge for Semaglutide as GLP-1 Drugs Struggle with Long-Term Adherence
In the weight-loss drug market, semaglutide was once seen as a rising star driving growth. However, a recent in-depth analysis has raised doubts about...
2024-07-12 18:07 -
The Growth and Challenges of Semaglutide: A New Weight-Loss Medication
Semaglutide, a novel weight-loss medication, has been the subject of much attention in the market.
2024-07-12 18:07 -
Hillevax's Challenges and Expansion Strategies in the Norovirus Vaccine Market
Hillevax's market capitalization has declined to $1,000,000, primarily due to the company's disclosure that its bivalent norovirus vaccine (HIL-218) f...
2024-07-12 18:06 -
HilleVax's Financial Performance: Navigating the Challenges of Vaccine Development
In the 2023 fiscal year, HilleVax's investment in research and development (R&D) increased significantly to $106.7 million, up from $45.9 million in t...
2024-07-12 18:05 -
Groundbreaking Approvals in Cell and Gene Therapies (CGTs) in the First Half of 2024
Cell and gene therapy (CGT) is an emerging treatment strategy that stands out for its potential "one-time treatment, permanent cure" capability, offer...
2024-07-12 18:03 -
The Surging Tide of Mergers and Collaborations in the Global Pharmaceutical Industry
As the global healthcare industry experiences a period of robust growth, the frequency of mergers and acquisitions (M&A) among pharmaceutical companie...
2024-07-11 17:56 -
Takeda's 2023 Fiscal Year: Navigating Challenges and Embracing Transformation
According to Takeda's 2023 fiscal year business report, the company's annual total revenue reached 4,263.8 billion yen, an increase of 5.9% year-over-...
2024-07-11 17:56
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
